Download
12889_2024_Article_18380.pdf 1,11MB
WeightNameValue
1000 Titel
  • How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany
1000 Autor/in
  1. Schmachtenberg, Tim |
  2. Königs, Gloria |
  3. Roder, Sascha |
  4. Müller, Frank |
  5. Müllenmeister, Christina |
  6. Schröder, Dominik |
  7. El-Sayed, Iman |
1000 Verlag BioMed Central
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-03-28
1000 Erschienen in
1000 Quellenangabe
  • 24(1):915
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12889-024-18380-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976759/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>Studies estimate that at least 7.5% of adults are affected by long-term symptoms such as fatigue or cognitive impairment after the acute phase of COVID-19. COVID-19 vaccination may reduce the risk of long COVID. Rehabilitation can have a positive impact on recovery. This study aims to present the experiences of people with long COVID with COVID-19 vaccination and rehabilitation. Such research is important because perceptions of these measures can impact healthcare utilization and health status.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>48 adults with long COVID participated in this qualitative study, 25 of them in one-on-one interviews and 23 in focus groups. Participants were recruited via calls for participation on the websites and social media channels of two university hospitals and with the help of respondents’ networks. The conversations were audio-recorded, transcribed, and analyzed using qualitative content analysis. Subsequently, the results were compared, interpreted, and discussed by scientific literature.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>35 study participants reported that they had received a COVID-19 vaccination and 16 of them stated that they had utilized a rehabilitation service. These participants had varying experiences with COVID-19 vaccination and rehabilitation. Nine of them stated that they developed long COVID despite vaccination before COVID-19. Ten participants reported vaccine reactions, and two participants reported severe side effects. Two participants reported persistent deterioration of their long COVID symptoms after vaccination. This led to uncertainty about the safety, benefits, and handling of COVID-19 vaccination. However, most participants perceived the vaccine as effective regarding milder COVID-19 sequelae. Four participants felt their rehabilitation was helpful and four participants felt it was unhelpful. Two persons found the combination of inpatient rehabilitation and rehabilitation sport helpful.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Several implications can be derived from this study: (1) researchers should explore the effects of COVID-19 vaccination on long COVID symptoms; (2) vaccination campaigns should be more responsive to the perspectives of people with long COVID on vaccination; (3) care planners should build rehabilitation facilities specialized in long COVID; (4) rehabilitation providers should train their professionals regarding long COVID and develop rehabilitation programs tailored to different clinical pictures.</jats:p> </jats:sec><jats:sec> <jats:title>Trial registration</jats:title> <jats:p>German register for clinical trials DRKS00026007, 09 September 2021.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Qualitative study
gnd 1206347392 COVID-19
lokal COVID-19 vaccination
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Germany
lokal COVID-19 Vaccines [MeSH]
lokal Post-Acute COVID-19 Syndrome [MeSH]
lokal Vaccines [MeSH]
lokal COVID-19/prevention
lokal Rehabilitation
lokal Research
lokal Long COVID
lokal European People [MeSH]
lokal Vaccination [MeSH]
lokal SARS-CoV-2
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2NobWFjaHRlbmJlcmcsIFRpbQ==|https://frl.publisso.de/adhoc/uri/S8O2bmlncywgR2xvcmlh|https://frl.publisso.de/adhoc/uri/Um9kZXIsIFNhc2NoYQ==|https://frl.publisso.de/adhoc/uri/TcO8bGxlciwgRnJhbms=|https://frl.publisso.de/adhoc/uri/TcO8bGxlbm1laXN0ZXIsIENocmlzdGluYQ==|https://frl.publisso.de/adhoc/uri/U2NocsO2ZGVyLCBEb21pbmlr|https://frl.publisso.de/adhoc/uri/RWwtU2F5ZWQsIEltYW4=
1000 Hinweis
  • DeepGreen-ID: 3a5dc38d25504403a9533a8cfef0d493 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Herzzentrum Göttingen |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Herzzentrum Göttingen |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6519605.rdf
1000 Erstellt am 2025-07-05T19:03:15.155+0200
1000 Erstellt von 322
1000 beschreibt frl:6519605
1000 Zuletzt bearbeitet 2025-08-14T07:30:01.506+0200
1000 Objekt bearb. Thu Aug 14 07:30:01 CEST 2025
1000 Vgl. frl:6519605
1000 Oai Id
  1. oai:frl.publisso.de:frl:6519605 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source